ArticleFrontiers in oncology2025

Leveraging transcriptomic, DNA methylation, and molecular alteration data to optimize the classification of IDH-mutant gliomas for therapy selection.

L Nicolas Gonzalez CastroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.